Matchpoint Therapeutics is a Biotech company based in Cambridge. It has raised $100M in total funding. Latest round: Series A.
Matchpoint Therapeutics is a Biotech company based in Cambridge. Matchpoint Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2022. The round record for Matchpoint Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Sanofi Ventures, Atlas Venture, Access Biotechnology, Vertex Ventures HC, Digitalis Ventures, Alexandria Venture Investments. 6 distinct backers are named across the disclosed rounds.
Round data for Matchpoint Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Cambridge and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026